Healthcare · Medical Devices · NASDAQ
| Market cap | $9.52B |
|---|---|
| Trailing P/E | 20.7 |
| Price / book | 6.0 |
| Price / sales | 3.0 |
| FCF yield | 3.5% |
| Dividend yield | — |
| Gross margin | 71.9% |
| Operating margin | 18.4% |
| Net margin | 13.4% |
| Revenue growth (YoY) | +30.7% |
| Revenue growth (3-yr annual) | +27.5% |
| EPS growth (YoY) | +49.5% |
| FCF/share growth (YoY) | +21.4% |
| Beta | 1.1 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
Next report: Feb 17, 2027 (Q4 2026, EPS estimate $1.75). Beat the EPS estimate in 4 of 4 recent quarters.
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 4, 2026 | $1.99 | $1.59 | +25.2% | $842.00M |
| Q2 2026 | Aug 5, 2026 | $1.66 | $1.45 | +14.5% | $801.70M |
| Q1 2026 | May 6, 2026 | $1.42 | $1.19 | +19.3% | $761.70M |
| Q4 2025 | Feb 18, 2026 | $1.55 | $1.46 | +6.2% | $783.80M |
Median target $179.00 from 23 analysts, ranging $160.00 – $200.00.
| Ticker | Company | Market cap | P/E |
|---|---|---|---|
| ABT | Abbott Laboratories | $179.90B | 19.3 |
| MDT | Medtronic | $128.69B | 17.6 |
| SYK | Stryker | $119.19B | 21.9 |
| BSX | Boston Scientific | $62.31B | 13.5 |
| EW | Edwards Lifesciences | $59.73B | 35.3 |
| GEHC | GE HealthCare Technologies | $37.03B | 16.7 |
| DXCM | DexCom | $29.91B | 30.0 |
| PHG | Koninklijke Philips | $28.60B | 14.7 |
Insulet trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Nov 10, 2026 |
| Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Oct 12, 2026 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Sep 10, 2026 |
| Daniel Goldman | House | Sell | $1,001 - $15,000 | Aug 13, 2023 |
| Tina Smith | Senate | Sell | $250,001 - $500,000 | — |
| Tina Smith | Senate | Sell | $15,001 - $50,000 | — |
| Tina Smith | Senate | Sell | $250,001 - $500,000 | — |
| Tina Smith | Senate | Sell | $100,001 - $250,000 | — |
| Tina Smith | Senate | Sell | $100,001 - $250,000 | — |